A GLOBAL SERVICE PROVIDER OF PRECLINICAL AND CLINICAL RESEARCH IN OPHTHALMOLOGY
Home » Services » Clinical trials » Clinical trial services » Phase 1-4 and marketing studies
Clinical trial services related to eye diseases
Iris Pharma carries out eye clinical research trials and studies (phase 1, phase 2, phase 3 and phase 4) and medico marketing studies throughout Western and Eastern Europe, North Africa, India and North America.
Learn more about our clinical capabilities:
The clinical trial services offered by Iris Pharma for clinical trials and clinical development include strategic trial planning, regulatory requirements, medical writing and clinical operations:
Strategy and advice for eye clinical research trials
- Study drug development consulting
- Study feasibility and design
- Support to investigators for non-commercial clinical trials
Regulatory requirements
Medical writing: expertise in eye diseases
- Writing protocols and study summaries
- Writing investigator´ brochures
- Review of the Investigational Medicinal Product Dossier (IMPD)
- Design of Case Report Forms (CRFs) and transcription to electronic Case Report Forms (eCRFs) if required
- Design of patient diaries
- Clinical study reports
- Publications
- Others medical writing
Clinical operations
- Selection of coordinating investigators and other investigators
- Site coordination
- Management of biological samples
- Management of investigational medicinal products
- Clinical monitoring according to GCP/ICH guidelines
- Investigators meetings and newsletters
- Safety surveillance
- Audits of centers
- Management of fees for investigators and hospitals
- Data management / statistics
- Archiving
